Department of General Surgery, First Medical Center of Chinese PLA General Hospital, 100853 Beijing, China.
Front Biosci (Landmark Ed). 2022 Sep 29;27(9):272. doi: 10.31083/j.fbl2709272.
BACKGROUND: Autophagy plays a pivotal role in the progression and management of colorectal cancer (CRC). Recently, numerous articles focusing on the role of autophagy in CRC have emerged. The present study was conducted to provide a comprehensive analysis of the current state and changing trends in the relationship of autophagy and CRC over the past 20 years. METHODS: The Web of Science Core Collection (WOSCC) was utilized to extracted all publications with respect to autophagy and CRC during 2002-2021. The contributions of various countries/regions, institutions and journals in this field were analyzed, moreover, research hotspots and promising future trends predicted through keywords were identified by the online platform of bibliometrics, CiteSpace and VOSviewer. RESULTS: A total of 2418 related publications from 2002 to 2021 were identified and collected. China occupied first place with respect to the number of publications, followed by the USA and South Korea. Shanghai Jiao Tong University published the most papers in this field. Most publications were published in Oncotarget. Additionally, analysis of the keywords identified 4 clusters with various research focuses: "mechanism-related research", "clinical-related research", "tumorigenesis research" and "chemotherapy-related research". The three latest hot keywords in this field were epithelial-mesenchymal transition (EMT), promote and invasion. CONCLUSIONS: The number of publications and research interest on autophagy and CRC are increasing annually, and the USA had prominent academic positions in the field. Shanghai Jiao Tong University represents a high level of research and the latest progress in this field can be tracked at Oncotarget. Throughout the research history of autophagy and CRC in the past 20 years, previous studies have mainly concentrated on apoptosis and drug resistance in tumor cells, while EMT in regulating tumorigenesis and development of clinical drugs that inhibit tumor invasion through autophagy may be novel hotspots in the future.
背景:自噬在结直肠癌(CRC)的发生和治疗中起着关键作用。最近,大量聚焦自噬在 CRC 中作用的文章不断涌现。本研究旨在对过去 20 年自噬与 CRC 关系的研究现状和变化趋势进行全面分析。
方法:利用 Web of Science 核心合集(WOSCC)检索 2002-2021 年间与自噬和 CRC 相关的所有出版物。分析了该领域不同国家/地区、机构和期刊的贡献,此外,通过文献计量学在线平台 CiteSpace 和 VOSviewer 分析关键词,预测研究热点和未来有前景的趋势。
结果:共检索到 2002 年至 2021 年与自噬和 CRC 相关的 2418 篇相关文献。中国在发表文献数量方面排名第一,其次是美国和韩国。上海交通大学在该领域发表的论文最多。大部分文献发表在 Oncotarget 杂志上。此外,通过关键词分析确定了 4 个具有不同研究重点的聚类:“机制相关研究”、“临床相关研究”、“肿瘤发生研究”和“化疗相关研究”。该领域的 3 个最新热门关键词是上皮-间充质转化(EMT)、促进和侵袭。
结论:自噬与 CRC 的文献数量和研究兴趣逐年增加,美国在该领域具有突出的学术地位。上海交通大学代表了该领域的高水平研究,在 Oncotarget 杂志上可以跟踪到该领域的最新进展。纵观过去 20 年自噬与 CRC 的研究历史,以往研究主要集中在肿瘤细胞的凋亡和耐药性上,而 EMT 在调节肿瘤发生和发展以及通过自噬抑制肿瘤侵袭的临床药物方面可能是未来的新热点。
Front Biosci (Landmark Ed). 2022-9-29
Front Cell Infect Microbiol. 2022
Medicine (Baltimore). 2023-11-3
Front Cell Infect Microbiol. 2023
Int Wound J. 2023-10
Oxid Med Cell Longev. 2023